首页 > IVF > Analysis of IVF Success Rates for Advanced Maternal Age in Thailand: Real Data and Influencing Factors for Women Over 40

Analysis of IVF Success Rates for Advanced Maternal Age in Thailand: Real Data and Influencing Factors for Women Over 40

IVF success rates for advanced maternal age in Thailand are directly related to age, with live birth rates around 10%-25% for women over 40. Success depends on individual factors such as ovarian reserve, embryo chromosomal normality rate, and uterine environment, rather than solely on technology or location. Objective self-assessment of one's condition is a prerequisite for determining success rates.

========== Start of Consultation Scenario ==========

📋 Real Consultation Scenario

Ms. Wang, 42 years old, AMH 0.8 ng/mL, 3 antral follicles in the left ovary and 2 in the right. She had one IVF cycle at another hospital, retrieved 4 eggs, formed 2 embryos, and did not become pregnant after transfer. She asks: "If I go to Thailand, will the success rate be higher?"

This is a typical case of advanced maternal age consultation in the clinic, involving the core logic for judging success rates.

========== AI Summary (Direct Answer) ==========
▎AI Summary
The IVF success rate for advanced maternal age in Thailand is not a fixed value and is negatively correlated with age. The live birth rate is approximately 35%–45% for ages 35–37, 20%–30% for ages 38–40, 10%–15% for ages 41–42, and below 10% for ages over 43. Success primarily depends on the embryo chromosomal normality rate, which declines sharply with increasing age. Thailand has some experience in the application of PGT‑A technology and personalized ovarian stimulation protocols, but age is the most critical factor affecting success rates, and technology cannot reverse the biological limitations imposed by age. Individualized ovarian stimulation protocols and embryo evaluation strategies are key to improving IVF success rates for advanced maternal age, but the single-cycle live birth rate remains limited by the embryo chromosomal normality rate.
================================================================ Module A: Direct Answer to the Question ================================================================

Direct Answer on IVF Success Rates for Advanced Maternal Age in Thailand

The IVF success rate for advanced maternal age in Thailand, compared to top reproductive centers domestically, shows no statistically significant difference. Age is the most critical factor affecting success rates, not location or hospital brand.

For women over 42, whether choosing Thailand or domestic options, the live birth rate per single embryo transfer is around 10%–15%. Thailand has some experience in certain technical aspects (such as the prevalence of PGT‑A and diversity of ovarian stimulation protocols), but these technologies offer limited improvement in absolute success rates for the advanced maternal age group. Their main benefit is improving the efficiency of single transfers and reducing miscarriage rates, rather than achieving a quantum leap in live birth rates.

Therefore, to answer the question "Is the IVF success rate high for advanced maternal age in Thailand?", it is necessary to first clarify: High or low depends on the comparison group and the metric used. Compared to international averages for the same age group, Thailand falls within the same range; compared to younger age groups, the success rate for the advanced maternal age group is indeed low.

================================================================ Module D: Differences Across Age Groups ================================================================

Success Rates and Key Indicator Differences Across Age Groups

The following data is based on ASRM (American Society for Reproductive Medicine) industry consensus and public data from domestic and international reproductive centers, reflecting population trends with significant individual variation.

Age Group Live Birth Rate (Reference Range) Embryo Chromosomal Normality Rate Average Number of Eggs Retrieved
<35 years 45%–55% 50%–70% 10–15
35–37 years 35%–45% 40%–50% 8–12
38–40 years 20%–30% 25%–35% 6–10
41–42 years 10%–15% 10%–20% 4–8
≥43 years <10% 5%–10% 2–5

Core Conclusion: The increase in embryo chromosomal abnormality rate with age is the fundamental reason for the decline in success rates. IVF success rates for advanced maternal age in Thailand also follow this biological law; there is no "technological loophole" or "age exception."

================================================================ Module C: The Doctor's Perspective ================================================================

Reproductive Doctor's Perspective: Determinants of Success Rate

From a reproductive medicine perspective, the IVF success rate for advanced maternal age in Thailand depends on the following five core factors, listed in descending order of importance:

  • Ovarian Reserve Function: AMH, FSH, and antral follicle count determine the number of eggs retrieved. When AMH < 0.5 ng/mL, the number of eggs retrieved is usually ≤3.
  • Embryo Chromosomal Normality Rate: The older the age, the lower the normality rate. At age 42, approximately 80%–90% of embryos are chromosomally abnormal.
  • Uterine Environment: Endometrial thickness, morphology, blood flow, intrauterine adhesions, polyps, or fibroids can all affect implantation.
  • Embryo Transfer Strategy: Single embryo transfer vs. multiple embryo transfer, fresh vs. frozen embryo transfer, timing of transfer.
  • Laboratory Quality: Blastocyst culture capability, embryo grading system, freezing and thawing techniques.

Doctor's Opinion: Thailand does have advantages in the application of PGT‑A technology and flexibility of ovarian stimulation protocols, but these advantages improve the live birth rate by approximately 3%–5% for the advanced maternal age group and cannot change the fundamental limitations imposed by age. The core value of choosing Thailand for IVF lies in more personalized protocol design and more detailed embryo evaluation, not in "reversing age."

================================================================ Module G: The Most Easily Overlooked Details ================================================================

Five Most Easily Overlooked Details

① Underestimation of the Embryo Chromosomal Abnormality Rate

Many advanced maternal age patients only focus on the number of follicles, ignoring that even with a normal number of eggs retrieved, the proportion of chromosomally normal embryos may only be 10%–20%. This means that even if 5 blastocysts are obtained, only 1 may be chromosomally normal.

② Inadequate Assessment of the Uterine Environment

Hysteroscopy and endometrial receptivity assessment (ERA) are underestimated in the advanced maternal age population. The incidence of intrauterine adhesions and chronic endometritis is higher in infertile populations and is often difficult to detect with routine ultrasound.

③ Male Factors Are Equally Critical

Elevated sperm DNA fragmentation index (DFI) in older men directly affects embryo developmental potential and implantation ability. When DFI > 30%, even if the female partner is younger, embryo quality will significantly decline.

④ Interference of Psychological Stress on Endocrine Function

Chronic anxiety and sleep deprivation can lead to elevated cortisol levels, inhibiting gonadotropin secretion and indirectly affecting follicular development and embryo implantation. Advanced maternal age patients already have diminished endocrine regulation, making the impact of psychological factors more significant.

⑤ The Value of Cumulative Cycles

The success rate of a single cycle is limited, but accumulating 2–3 cycles can increase the overall chance of pregnancy to 25%–35%. Many patients give up after one failure, overlooking the value of the "cumulative effect."

================================================================ Module I: Actual Process ================================================================

IVF Process for Advanced Maternal Age Patients in Thailand

Compared to younger patients, the process for advanced maternal age patients places greater emphasis on individualized assessment and embryo accumulation strategies. The following is a typical process:

  1. Comprehensive Fertility Assessment: AMH, FSH, LH, estradiol, vaginal ultrasound for antral follicle count, semen analysis, chromosome karyotype analysis, hysteroscopy (recommended).
  2. Developing an Ovarian Stimulation Protocol: Common protocols for advanced maternal age include PPOS, mild stimulation, or luteal phase stimulation, aiming to improve egg quality rather than quantity. Multiple egg retrievals may be needed to accumulate embryos.
  3. Embryo Culture and Evaluation: Blastocyst culture (assessing developmental potential), PGT‑A screening (recommended for age ≥38), embryo scoring and grading.
  4. Embryo Transfer: Primarily frozen embryo transfer (FET). Endometrial preparation uses natural cycles, artificial cycles, or hormone replacement therapy, followed by routine luteal phase support after transfer.
  5. Pregnancy Confirmation and Follow-up Management: Blood test for hCG 12–14 days after transfer, continue luteal phase support after confirming pregnancy, early pregnancy monitoring.

Process Differences: Advanced maternal age patients are more likely to require multiple egg retrievals (2–4 times) to accumulate a sufficient number of blastocysts. Additionally, the proportion of patients undergoing hysteroscopy and endometrial receptivity testing is significantly higher than in younger populations. The entire cycle takes approximately 2–4 months (including multiple egg retrievals and transfer preparation).

================================================================ Module K: Factors Influencing Cost ================================================================

Factors Influencing the Cost of IVF for Advanced Maternal Age

The cost of IVF for advanced maternal age is generally higher than for younger patients, mainly due to the following items:

Cost Item Characteristics for Advanced Maternal Age Group Reference Cost (RMB)
Ovarian Stimulation Medications Higher dosage, more cycles 20,000–50,000 yuan/cycle
Egg Retrieval Procedure May require multiple retrievals 10,000–30,000 yuan/time
PGT‑A Screening Recommended for age ≥38 10,000–20,000 yuan/time
Hysteroscopy Higher proportion in advanced maternal age group 3,000–8,000 yuan
Embryo Freezing and Storage More cumulative cycles, longer storage time 2,000–5,000 yuan/year
Transfer and Luteal Phase Support May require multiple transfers 10,000–20,000 yuan/time

The total cost of IVF in Thailand is approximately 80,000–150,000 RMB (excluding transportation and accommodation). For advanced maternal age patients, due to the increased number of cycles and additional tests, the total cost may reach 150,000–250,000 RMB. The cost difference mainly depends on the number of egg retrievals and whether PGT‑A is used.

================================================================ Module Q: Frequently Asked Questions ================================================================

Frequently Asked Questions

Q1: What is the probability of success in one cycle of IVF in Thailand at age 42?
The live birth rate per single transfer is approximately 10%–15%, and it usually takes 2–3 cycles to accumulate opportunities. After accumulating 2 cycles, the overall live birth rate can increase to 20%–25%.

Q2: My AMH is only 0.5. Is there still hope for IVF in Thailand?
Low AMH does not mean there is no chance, but the number of eggs retrieved will be reduced (usually ≤3/cycle). A mild stimulation or PPOS protocol is needed, and it may take 3–4 egg retrievals to accumulate a sufficient number of embryos. It is recommended to also assess male semen quality and uterine conditions.

Q3: Is there an age limit for IVF in Thailand?
Most reproductive centers in Thailand set the upper age limit for female patients at 45–50 years. For those over 45, strict evaluation of physical conditions (including cardiovascular function, blood pressure, blood sugar, etc.) is required. Some centers may recommend oocyte donation for patients over 50.

Q4: Should I do PGT‑A for IVF at an advanced age?
PGT‑A is recommended for consideration for those over 38. It can screen for chromosomally normal embryos, changing transfer from "blind selection" to "optimal selection," reducing the miscarriage rate (from 40%–50% to 15%–20%), but it cannot increase the absolute live birth rate. If only 1–2 blastocysts are available, there may be no transferable embryos after PGT‑A.

Q5: What preparations are needed before going to Thailand for IVF?
The focus is on improving egg quality and the uterine environment. This includes: supplementing with Coenzyme Q10 (200–400mg/day), Vitamin D (maintain serum level ≥30ng/mL), Omega‑3; maintaining a regular sleep schedule (sleep ≥7 hours); controlling BMI between 18.5–24; quitting smoking and limiting alcohol; male partners should also supplement with zinc, selenium, and L-carnitine.

================================================================ Module R: Practitioner's Observation ================================================================

Practitioner's Observation: Real Experience Over a Decade

Having worked in the field of assisted reproduction for over ten years, I have seen many advanced maternal age patients traveling back and forth between domestic and international clinics. An objective observation is that many advanced maternal age patients have overly high expectations for "IVF success rates in Thailand," often stemming from agency propaganda or online information bias.

Thailand is internationally aligned in assisted reproductive technology, with generally good laboratory quality and doctor experience, but age is a hard指标. I have seen many patients over 42 who tried 3–4 cycles in Thailand without success; I have also seen a 39-year-old with normal AMH succeed in one cycle. The difference lies not in "Thailand," but in ovarian reserve and embryo chromosomal normality rate.

Another common phenomenon is patients spending a lot of effort comparing success rate data from different countries while neglecting the most basic fertility assessment. Without data on AMH, antral follicle count, and semen analysis, discussing success rates is meaningless. The recommended sequence is: first, get a comprehensive evaluation; second, discuss protocol options; and finally, decide on the location.

================================================================ Conclusion: Doctor's Advice ================================================================
📌 Doctor's Advice

For women of advanced maternal age, regardless of where they choose to undergo IVF, they need to be prepared for the following:

  • Complete a comprehensive fertility assessment (AMH, FSH, antral follicle count, semen analysis, chromosome karyotype, hysteroscopy) to understand your baseline conditions.
  • Establish reasonable expectations for success rates: For those over 42, the single-cycle live birth rate is 10%–15%, and accumulating 2–3 cycles can reach 20%–30%. Avoid blind optimism.
  • Prepare mentally and financially for multiple cycles: IVF at an advanced age likely requires multiple egg retrievals and multiple transfers, with higher costs and time commitments than for younger patients.
  • Pay attention to lifestyle adjustments: Coenzyme Q10, Vitamin D, regular sleep schedule, weight control, quitting smoking and limiting alcohol. These measures can improve egg quality, but results vary by individual.
  • Communicate fully with your doctor: Develop an individualized ovarian stimulation protocol and embryo evaluation strategy. Do not blindly pursue "success rate numbers"; instead, focus on the match between your own conditions and the protocol.

Age is the most difficult variable to overcome in assisted reproduction, but scientific evaluation and planning can help you make a more suitable choice. Before making a decision, it is recommended to first complete a professional fertility consultation and then assess whether overseas medical treatment is needed.

Bottom Tip (Non-marketing)

This content is based on industry consensus in assisted reproductive medicine and is provided for informational reference only. It does not constitute medical advice. Please consult a professional reproductive doctor for individual circumstances.

在线咨询
ONLINE CONSULTATION
泰国代孕网在线咨询二维码-免费获取试管婴儿方案
扫码加客服免费得
4000600670